Google DeepMind's Antigravity platform finds antimicrobial peptide candidate
Google DeepMind's Antigravity platform, using its Cheminformatics Skills, searched compounds and proposed novel rigidified macrocycles for drug discovery.
By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .
This story is no longer being updated. It reflects reporting up to .
What happened
Google DeepMind's Antigravity platform, using its Cheminformatics Skills, searched compounds and proposed novel rigidified macrocycles for drug discovery. The platform linked more than 30 scientific databases and identified a new antimicrobial peptide candidate. The candidate showed promising activity against a respiratory pathogen, but physical experiments have not yet confirmed it.
Why it matters
The candidate is now in wet-lab validation, the next step in testing whether it works. The reports describe the work as accelerating drug discovery workflows.
Timeline
- Nov 3, 10:00 AM ET: Google described how Antigravity and its Cheminformatics Skills speed up compound search and macrocycle design.
- Nov 3, 6:08 PM ET: The antimicrobial peptide candidate showed promising activity against a respiratory pathogen, though physical experiments have not confirmed it.
Coverage
- Google DeepMind Enhances Drug Discovery with AI-Powered Agentic Cheminformatics (thechenabtimes.com)
More from Technology & AI
- China puts humanoid robots to work serving food and sorting parcels
- Newsom proposes sweeping AI safety rules for Washington
- Google releases Gemini 4 Neon AI model with million-token context
- Microsoft and Intel widen their cloud chip partnership
- Google DeepMind rolls out Genie 4 to select subscribers
- AI helped AMD shorten chip design work, OpenAI says